benchmark
Showing 51 - 75 of 756
Epstein-Barr Virus Infection Trial in United States (mRNA-1195.1, mRNA-1195.2, mRNA-1189)
Recruiting
- Epstein-Barr Virus Infection
- mRNA-1195.1
- +3 more
-
Anniston, Alabama
- +29 more
Apr 14, 2023
Lumbar Spinal Stenosis Trial in Canton (electric dry needling, manipulation, conventional physical therapy)
Completed
- Lumbar Spinal Stenosis
- electric dry needling, manipulation
- conventional physical therapy
-
Canton, GeorgiaBenchmark PT - Canton
Dec 28, 2020
Influenza, Human Trial in United States (PF-07852352 Influenza saRNA 1, PF-07836391 Influenza saRNA, PF-07836394 Influenza
Recruiting
- Influenza, Human
- PF-07852352 Influenza saRNA 1
- +10 more
-
Phoenix, Arizona
- +23 more
Jan 17, 2023
Influenza, Human Trial in United States (Quadrivalent influenza modRNA vaccine, Quadrivalent influenza vaccine)
Recruiting
- Influenza, Human
- Quadrivalent influenza modRNA vaccine
- Quadrivalent influenza vaccine
-
Athens, Alabama
- +92 more
Sep 15, 2022
RSV Trial in United States (RSVpreF (Group 1), RSVpreF (Group 2), RSVpreF (Group 3))
Recruiting
- RSV
- RSVpreF (Group 1)
- +3 more
-
Miami Lakes, Florida
- +18 more
Mar 10, 2022
Pneumococcal Infection Trial in Puerto Rico, United States (V110, V114, mRNA-1273)
Recruiting
- Pneumococcal Infection
- V110
- +4 more
-
North Hollywood, California
- +45 more
Aug 11, 2022
Meningococcal Vaccine Trial in Worldwide (MenABCWY, Saline, rLP2086)
Completed
- Meningococcal Vaccine
- MenABCWY
- +3 more
-
Birmingham, Alabama
- +68 more
Jan 23, 2023
Spinal Cord Injuries Trial in Australia (Pregabalin, Placebo for pregabalin)
Terminated
- Spinal Cord Injuries
- Pregabalin
- Placebo for pregabalin
-
Randwick, New South Wales, Australia
- +3 more
Jan 21, 2021
Meningococcal Vaccine Trial in United States (MenABCWY, Saline)
Active, not recruiting
- Meningococcal Vaccine
- MenABCWY
- Saline
-
Mobile, Alabama
- +19 more
Feb 15, 2022
Ear Anatomy Trial in Stäfa (Standard Impression technique, Direct Ear Scanner)
Completed
- Ear Anatomy
- Standard Impression technique
- Direct Ear Scanner
-
Stäfa, SwitzerlandSonova AG
Nov 25, 2019
Seasonal Influenza Trial in United States (mRNA-1010, Placebo, Active Comparator)
Recruiting
- Seasonal Influenza
- mRNA-1010
- +2 more
-
Phoenix, Arizona
- +20 more
Apr 7, 2022
Cardiovascular Diseases (CVD) Trial in Basel (Data collection at Baseline, 3 months after baseline (BL), 1-year follow-up,
Recruiting
- Cardiovascular Diseases (CVD)
- Data collection at Baseline, 3 months after baseline (BL), 1-year follow-up, Telephone follow-up and questionnaire 3 years and 5 years after BL
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Outpatient Cardiology
Aug 10, 2022
Pneumococcal Disease Trial in United States (Experimental 20-valent pneumococcal conjugate vaccine (20vPnC), Saline, Influenza
Completed
- Pneumococcal Disease
- Experimental 20-valent pneumococcal conjugate vaccine (20vPnC)
- +2 more
-
Mobile, Alabama
- +62 more
Jun 15, 2022
Influenza Vaccine Trial in United States (TIV, Trivalent Inactivated Influenza Virus Vaccine, FluMist, Influenza Virus Vaccine
Completed
- Influenza Vaccine
- TIV, Trivalent Inactivated Influenza Virus Vaccine
- FluMist, Influenza Virus Vaccine Live
-
Jonesboro, Arkansas
- +18 more
Sep 10, 2021
Swedish National Benchmarks in Laparoscopic Bariatric Surgery
Completed
- Bariatric Surgery
- Laparoscopic Bariatric Surgery
- (no location specified)
Mar 24, 2023
Commercial Typhoid Tests Validation
Not yet recruiting
- Typhoid Fever
- 1. SD Bioline Salmonella Typhi IgG/IgM Fast test, 2. Typhidot Rapid IgG/IgM combo test, 3. TUBEX TF test, 4.Typhoid IgG/IgM Combo Rapid Test CE, 5. Enterocheck WB test, 6. Test-itTM Typhoid IgM test
-
Nairobi, KenyaKenya Medical Research Institute
Dec 12, 2020
SARS-CoV-2 Infection Trial in Worldwide (Intramuscular injection, Intramuscular vaccine)
Active, not recruiting
- SARS-CoV-2 Infection
- Intramuscular injection
- Intramuscular vaccine
-
Birmingham, Alabama
- +90 more
Apr 4, 2022
Chronic Heart Failure Trial in United States (Placebo, rhNRG-1 Dose 1, rhNRG-1 Dose 2)
Completed
- Chronic Heart Failure
- Placebo
- +2 more
-
La Jolla, California
- +12 more
Apr 22, 2021
Pneumococcal Disease, COVID-19, SARS-CoV-2 Infection Trial in United States (20-valent pneumococcal conjugate vaccine (20vPnC),
Completed
- Pneumococcal Disease
- +2 more
- 20-valent pneumococcal conjugate vaccine (20vPnC)
- +2 more
-
Anaheim, California
- +28 more
Mar 23, 2022
Human Metapneumovirus and Human Parainfluenza Infection Trial in Omaha, Austin, Fort Worth (mRNA-1653, Placebo)
Completed
- Human Metapneumovirus and Human Parainfluenza Infection
- mRNA-1653
- Placebo
-
Omaha, Nebraska
- +2 more
Feb 5, 2020
Celiac Disease Trial in Oslo (Randomized, controlled trial (RCT) with parallel arms and double blinded)
Recruiting
- Celiac Disease
- Randomized, controlled trial (RCT) with parallel arms and double blinded
-
Oslo, NorwayOslo Metropolitan University
Apr 18, 2022
Idiopathic Pulmonary Fibrosis Trial in Worldwide (MBS2320, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- MBS2320
- Placebo
-
Fresno, California
- +59 more
Jul 10, 2023
COVID-19 Trial in United States (NVX-CoV2373 (5µg), NVX-CoV2601 (5µg), NVX-CoV2601(5µg))
Not yet recruiting
- COVID-19
- NVX-CoV2373 (5μg)
- +6 more
-
Birmingham, Alabama
- +47 more
Jul 2, 2023
FebriDx DISRUPT Acute Respiratory Infection Trial in Acute
Completed
- Acute Respiratory Tract Infections
- FebriDx
-
Birmingham, Alabama
- +19 more
Jun 15, 2021